Ensuring Translational Success by Futureproofing Your Program: Preclinical Model Selection & Predictive Biomarker Screening
Time: 1:00 pm
day: Pre-Conference Workshop Day
Details:
Dive into discussions on how to maximize the developability of your pre-clinical cytokine efforts through to the clinic and beyond. Explore the intricacies of preclinical models for cytokine therapeutic development and start early thinking for patient selection and dose profiling. Join this workshop to:
- Navigate what steps can be taken in early development to improve translation and clinical success • Hear learnings from organizations in the clinic to de-risk your pipeline
- Uncover next generation in-vivo and in-vitro models • Assess how to design your IND enabling toxicology study to reduce cost
- Explore patient selection, using predictive biomarkers and predictive modelling for clinical success • Discuss PKPD modelling, predicting the right dose and using dose regimens
- Can preclinical models help with clinical development?
